XML 67 R54.htm IDEA: XBRL DOCUMENT v3.21.2
License, collaboration and commercial agreements - Secura Bio Inc (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 25, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Milestone
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Milestone
Sep. 30, 2020
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Revenue recognized     $ 2   $ 78,647 $ 1,508 $ 88,010
Cost of sales - sale of COPIKTRA license and related assets         31,187   31,187
Copiktra license and related assets              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Revenue recognized         70,000 902 70,000
Transition Services Revenue              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Revenue recognized     2     606  
License and Collaboration Agreement | Secura              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Upfront payment   $ 70,000          
Regulatory milestone payments       $ 800      
Milestone payments receivable upon approval of COPIKTRA   35,000     35,000   35,000
Milestone payments receivable upon approval for commercial sale   10,000     10,000   10,000
Threshold sales to trigger royalty payments   $ 100,000          
Percentage of all royalty, milestone and sublicense revenue payments payable   50.00%          
Percentage of all royalty and milestone payments payable under certain jurisdictions   50.00%          
Term of agreement   1 year          
Number of days written prior notice required for other party to terminate agreement   5 days          
Future potential royalties expected to be received     100     100  
Cost of sales - sale of COPIKTRA license and related assets         31,200   31,200
Percentage of share on regulatory milestone achieved       50.00%      
License and Collaboration Agreement | Secura | Copiktra license and related assets              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Regulatory milestone payments     800     800  
Revenue recognized     0   70,000 $ 900 70,000
Number of regulatory milestone achieved | Milestone           1  
License and Collaboration Agreement | Secura | Transition Services Revenue              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Revenue recognized     $ 0     $ 600  
License and Collaboration Agreement | Secura | Sales Exceeds $100 Million              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Sales milestone receivable   $ 10,000     10,000   10,000
Threshold sales to trigger milestone payments   100,000          
License and Collaboration Agreement | Secura | Sales Exceeds $200 Million              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Sales milestone receivable   15,000     15,000   15,000
Threshold sales to trigger milestone payments   200,000          
License and Collaboration Agreement | Secura | Sales Exceeds $300 Million              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Sales milestone receivable   25,000     25,000   25,000
Threshold sales to trigger milestone payments   300,000          
License and Collaboration Agreement | Secura | Maximum              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Regulatory milestone payments   45,000     45,000   45,000
Sales milestone receivable   $ 50,000     50,000   50,000
License and Collaboration Agreement | Secura | Intangible asset              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Cost of sales - sale of COPIKTRA license and related assets         19,200   19,200
License and Collaboration Agreement | Secura | Duvelisib inventory              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Cost of sales - sale of COPIKTRA license and related assets         6,000   6,000
License and Collaboration Agreement | Secura | Manufacturing equipment              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Cost of sales - sale of COPIKTRA license and related assets         200   200
License and Collaboration Agreement | Secura | Duvelisib contract prepaid balances              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Cost of sales - sale of COPIKTRA license and related assets         $ 5,800   $ 5,800
License and Collaboration Agreement | Sanofi              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Maximum aggregate payments entitled to receive if all milestones successfully achieved $ 42,000            
Number of regulatory milestone achieved | Milestone       1